Biotech · Private company
Cassava Sciences, Inc.
Track this companyFree. Adds Cassava Sciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials90 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- SimufilamPhase 3 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- simufilamPhase 2 · Alzheimer's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Simufilam 100 mg oral tabletPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Simufilam 100 mg tabletPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Simufilam 50 mg oral tabletPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- simufilamPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- SimufilamPhase 1 · AbsorptionClinicalTrials.gov · fetched Nov 12, 2026
- SimufilamPhase 1 · Hepatic InsufficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic FunctionPHASE1 · COMPLETED · started Jun 26, 2024ClinicalTrials.gov NCT06390410 · fetched Nov 12, 2026
- Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-Simufilam Following a Single Oral Dose in Healthy Male SubjectsPHASE1 · COMPLETED · started Feb 7, 2024ClinicalTrials.gov NCT06195319 · fetched Nov 12, 2026
- Open-label Extension for Phase 3 Clinical Trials of SimufilamPHASE3 · TERMINATED · started Nov 7, 2022ClinicalTrials.gov NCT05575076 · fetched Nov 12, 2026
- Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's DiseasePHASE2 · TERMINATED · started May 12, 2022ClinicalTrials.gov NCT05352763 · fetched Nov 12, 2026
- Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's DiseasePHASE3 · TERMINATED · started Nov 18, 2021ClinicalTrials.gov NCT05026177 · fetched Nov 12, 2026
- Simufilam 100 mg for Mild-to-Moderate Alzheimer's DiseasePHASE3 · COMPLETED · started Nov 3, 2021ClinicalTrials.gov NCT04994483 · fetched Nov 12, 2026
- Food Effect and Bioequivalence Study of Simufilam Tablets in Healthy VolunteersPHASE1 · COMPLETED · started May 4, 2021ClinicalTrials.gov NCT04932655 · fetched Nov 12, 2026
- Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease PatientsPHASE2 · COMPLETED · started Mar 24, 2020ClinicalTrials.gov NCT04388254 · fetched Nov 12, 2026
- PTI-125 for Mild-to-moderate Alzheimer's Disease PatientsPHASE2 · COMPLETED · started Sep 9, 2019ClinicalTrials.gov NCT04079803 · fetched Nov 12, 2026